Wall Street Zen raised Lucid Diagnostics from a “sell” rating to a “hold” rating in a research note on Sunday, September 28th. Lucid Diagnostics Price PerformanceShares of Lucid Diagnostics stock opened at $1.02 on Tuesday. Lucid Diagnostics has a 52-week low of $0.75 and a 52-week high of $1.80. Lucid Diagnostics Company Profile(Get Free Report)Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. Recommended StoriesReceive News & Ratings for Lucid Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucid Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.